Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Childress

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
CNS Drugs|August 13, 2015
Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of PharmacotherapyAnn C Childress, Floyd R Sallee
Expert Review of Neurotherapeutics|January 17, 2012
The use of lisdexamfetamine dimesylate for the treatment of ADHDAnn C Childress, Floyd R Sallee
Drugs of Today (Barcelona, Spain : 1998)|March 31, 2012
Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorderA C Childress, F R Sallee
Drugs|February 10, 2012
Pharmacotherapy of attention-deficit hyperactivity disorder in adolescentsAnn C Childress, Sally A Berry
Postgraduate Medicine|September 24, 2010
The single-dose pharmacokinetics of NWP06, a novel extended-release methylphenidate oral suspensionAnn C Childress, Sally A Berry
CNS Drugs|January 10, 2014
Attention-deficit/hyperactivity disorder with inadequate response to stimulants: approaches to managementAnn C Childress, Floyd R Sallee
Expert Opinion on Drug Metabolism & Toxicology|October 5, 2019
An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulationsAnn C Childress, Marina Komolova, F Randy Sallee
Neuropsychiatric Disease and Treatment|June 10, 2011
Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom studyFrank A López, Brian Scheckner, Ann C Childress
CNS Drugs|December 15, 2022
Early Morning ADHD Symptoms and Functional Impairment: Impact on Patients and Caregivers, and Pharmacological Approaches to ManagementAnn C Childress, Kenisha R Yu, Lewis Cuthbertson
The Laryngoscope|September 25, 2001
Sinusitis complicated by meningitis: current managementR T Younis, V K Anand, C Childress
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
CNS Drugs|August 13, 2015
Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of PharmacotherapyAnn C Childress, Floyd R Sallee
Expert Review of Neurotherapeutics|January 17, 2012
The use of lisdexamfetamine dimesylate for the treatment of ADHDAnn C Childress, Floyd R Sallee
Drugs of Today (Barcelona, Spain : 1998)|March 31, 2012
Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorderA C Childress, F R Sallee
Drugs|February 10, 2012
Pharmacotherapy of attention-deficit hyperactivity disorder in adolescentsAnn C Childress, Sally A Berry
Postgraduate Medicine|September 24, 2010
The single-dose pharmacokinetics of NWP06, a novel extended-release methylphenidate oral suspensionAnn C Childress, Sally A Berry
CNS Drugs|January 10, 2014
Attention-deficit/hyperactivity disorder with inadequate response to stimulants: approaches to managementAnn C Childress, Floyd R Sallee
Expert Opinion on Drug Metabolism & Toxicology|October 5, 2019
An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulationsAnn C Childress, Marina Komolova, F Randy Sallee
Neuropsychiatric Disease and Treatment|June 10, 2011
Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom studyFrank A López, Brian Scheckner, Ann C Childress
CNS Drugs|December 15, 2022
Early Morning ADHD Symptoms and Functional Impairment: Impact on Patients and Caregivers, and Pharmacological Approaches to ManagementAnn C Childress, Kenisha R Yu, Lewis Cuthbertson
The Laryngoscope|September 25, 2001
Sinusitis complicated by meningitis: current managementR T Younis, V K Anand, C Childress
Pageof 9